Sutherland RL - Search Results

1

Targeting cyclin-dependent kinase 1 (CDK1) but not CDK4/6 or CDK2 is selectively lethal to MYC-dependent human breast cancer cells.

Kang J, Sergio CM, Sutherland RL, Musgrove EA. Kang J, et al. Among authors: sutherland rl. BMC Cancer. 2014 Jan 20;14:32. doi: 10.1186/1471-2407-14-32. BMC Cancer. 2014. PMID: 24444383 Free PMC article.

2

p27(Kip1) induces quiescence and growth factor insensitivity in tamoxifen-treated breast cancer cells.

Carroll JS, Lynch DK, Swarbrick A, Renoir JM, Sarcevic B, Daly RJ, Musgrove EA, Sutherland RL. Carroll JS, et al. Among authors: sutherland rl. Cancer Res. 2003 Aug 1;63(15):4322-6. Cancer Res. 2003. PMID: 12907598

3

The cyclin-dependent kinase inhibitor p27 (Kip1) regulates both DNA synthesis and apoptosis in mammary epithelium but is not required for its functional development during pregnancy.

Davison EA, Lee CS, Naylor MJ, Oakes SR, Sutherland RL, Hennighausen L, Ormandy CJ, Musgrove EA. Davison EA, et al. Among authors: sutherland rl. Mol Endocrinol. 2003 Dec;17(12):2436-47. doi: 10.1210/me.2003-0199. Epub 2003 Aug 21. Mol Endocrinol. 2003. PMID: 12933906

4

Cyclins and breast cancer.

Sutherland RL, Musgrove EA. Sutherland RL, et al. J Mammary Gland Biol Neoplasia. 2004 Jan;9(1):95-104. doi: 10.1023/B:JOMG.0000023591.45568.77. J Mammary Gland Biol Neoplasia. 2004. PMID: 15082921 Review.

5

Regulation of cyclin expression and cell cycle progression in breast epithelial cells by the helix-loop-helix protein Id1.

Swarbrick A, Akerfeldt MC, Lee CS, Sergio CM, Caldon CE, Hunter LJ, Sutherland RL, Musgrove EA. Swarbrick A, et al. Among authors: sutherland rl. Oncogene. 2005 Jan 13;24(3):381-9. doi: 10.1038/sj.onc.1208188. Oncogene. 2005. PMID: 15489884

6

Deregulated cyclin D1 expression is associated with decreased efficacy of the selective epidermal growth factor receptor tyrosine kinase inhibitor gefitinib in head and neck squamous cell carcinoma cell lines.

Kalish LH, Kwong RA, Cole IE, Gallagher RM, Sutherland RL, Musgrove EA. Kalish LH, et al. Among authors: sutherland rl. Clin Cancer Res. 2004 Nov 15;10(22):7764-74. doi: 10.1158/1078-0432.CCR-04-0012. Clin Cancer Res. 2004. PMID: 15570011

7

Downstream targets of growth factor and oestrogen signalling and endocrine resistance: the potential roles of c-Myc, cyclin D1 and cyclin E.

Butt AJ, McNeil CM, Musgrove EA, Sutherland RL. Butt AJ, et al. Among authors: sutherland rl. Endocr Relat Cancer. 2005 Jul;12 Suppl 1:S47-59. doi: 10.1677/erc.1.00993. Endocr Relat Cancer. 2005. PMID: 16113099 Review.

8

Cell cycle control in breast cancer cells.

Caldon CE, Daly RJ, Sutherland RL, Musgrove EA. Caldon CE, et al. Among authors: sutherland rl. J Cell Biochem. 2006 Feb 1;97(2):261-74. doi: 10.1002/jcb.20690. J Cell Biochem. 2006. PMID: 16267837 Review.

9

c-Myc overexpression and endocrine resistance in breast cancer.

McNeil CM, Sergio CM, Anderson LR, Inman CK, Eggleton SA, Murphy NC, Millar EK, Crea P, Kench JG, Alles MC, Gardiner-Garden M, Ormandy CJ, Butt AJ, Henshall SM, Musgrove EA, Sutherland RL. McNeil CM, et al. Among authors: sutherland rl. J Steroid Biochem Mol Biol. 2006 Dec;102(1-5):147-55. doi: 10.1016/j.jsbmb.2006.09.028. Epub 2006 Oct 18. J Steroid Biochem Mol Biol. 2006. PMID: 17052904

10

Progestins reinitiate cell cycle progression in antiestrogen-arrested breast cancer cells through the B-isoform of progesterone receptor.

McGowan EM, Russell AJ, Boonyaratanakornkit V, Saunders DN, Lehrbach GM, Sergio CM, Musgrove EA, Edwards DP, Sutherland RL. McGowan EM, et al. Among authors: sutherland rl. Cancer Res. 2007 Sep 15;67(18):8942-51. doi: 10.1158/0008-5472.CAN-07-1255. Cancer Res. 2007. PMID: 17875737

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

391 results

Search Page

Filters